Pharmafile Logo
Pharmafocus logo
Advanced Search

New NICE recommendation for Astellas prostate cancer drug

June 8, 2021
Manufacturing and Production Astellas, NICE, prostate cancer

A newly published Final Appraisal Determination by NICE has recommended Astellas’ Xtandi (enzalutamide) plus androgen deprivation therapy (ADT), as an …

News

Astronomy & cancer: Researchers join forces to study CUP

June 7, 2021
Sales and Marketing oncology

Astronomers from Durham University have joined forces with cancer researchers to advance the diagnosis and treatment of cancer of unknown …

News

UK vaccination update

June 7, 2021
Sales and Marketing

With 21 June fast approaching, and the Delta variant rising in the UK, here’s the latest vaccine update. Firstly, the …

News

AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions

June 7, 2021
Sales and Marketing AstraZeneca, GSK, court

AstraZeneca has launched a court case against Glaxo Smith Kline (GSK), in a claim that could reach hundreds of millions …

News
covid_cell_1_20

MHRA confirms registration of Avacta’s lateral flow test

June 7, 2021
Sales and Marketing COVID-19, EU, MHRA, lateral flow test

Avacta has announced that the MHRA has confirmed registration of the AffiDX SARS-CoV-2 antigen lateral flow test, which allows the …

News
regeneron

Regeneron’s COVID-19 antibody EUA reduced to lower dose by FDA

June 7, 2021
Sales and Marketing

The FDA has updated the Emergency Use Authorisation (EUA) for Regeneron Pharmaceuticals’ COVID-19 antibody cocktail, REGEN-COV, halving the dose from …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

June 4, 2021
Medical Communications

Among our ten most-read stories this week: NICE rejects risdiplam for treating spinal muscular atrophy; The EU wants to Fine …

News
novartis_window

Novartis’s 177Lu-PSMA-617 reduces prostate cancer death risk by 38%

June 4, 2021
Medical Communications

Novartis’s 177Lu-PSMA-617 has shown to significantly improve overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer …

News

BMS announce new positive data from oesophageal cancer study

June 4, 2021
Medical Communications Cancer, oncology

Bristol Myers Squibb (BMS) has announced results from the Phase III CheckMate -648 trial in which nivolumab plus chemotherapy and …

News

Phase III trial shows Olaparib reduces breast cancer recurrence by 42%

June 4, 2021
Medical Communications

Results from OlympiA’s Phase III trial has shown that its Olaparib (Lynparza) in the adjuvant treatment of patients with germline …

News

J&J’s Tremfya sees positive results for post-TNFi psoriatic arthritis

June 4, 2021
Medical Communications J&J, JJ

Johnson & Johnson’s interleukin-23 (IL-23) Tremfya (guselkumab) has shown positive results in Phase IIIb trials, in post-tumour necrosis factor (TNF) …

News
cdc-un8tv9pw2ik-unsplash_1

WHO approves China’s Sinovac COVID-19 vaccine

June 3, 2021

China’s Sinovac COVID-19 vaccination has received an emergency use listing (EUL) from the WHO. This decision means the jab can …

News
hd_map

Vaccine patch outperforms needle-and-syringe jabs in pre-clinical study

June 3, 2021
COVID-19, Vaccine, technology

Vaxxas, an Australian clinical-stage biotechnology company, has announced positive results from pre-clinical trials into its novel high-density microarray patch (HD-MAP) …

News

Phase III traumatic brain injury trial does not meet primary endpoint

June 3, 2021

vasopharm GmbH has announced that its NOSTRA III traumatic brain injury (TBI) Phase III clinical trial of ronopterin did not …

News

Novartis report longest median OS in breast cancer study

June 3, 2021
Novartis, breast cancer, trials

Novartis has announced updated median overall survival (OS) results for Kisqali (ribociclib), in combination with fulvestrant, in postmenopausal women with …

News

Organon launches as women’s health company

June 3, 2021

Organon has today launched through a spinoff from Merck as a global company focusing on women’s health. The new team …

News

Biosimilars and Brexit: What’s in store for UK’s biosimilar market?

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, brexit

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …

Feature

The importance of representation in clinical trials

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Representation, clinical trials

Before any kind of new medicine can be made available to the market, it has to go through a strictly …

Feature

Softbox brings in Sean Austerberry as new Director

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Softbox Systems has appointed Sean Austerberry as its Research and Product Development Director. Sean will be responsible for all of …

Appointment
robert_obeirn

Sharp adds Robert O’Beirn to its Global Clinical Services Business

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sharp has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. In early 2019 Mr …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025